BackBackDiluted net income available to common stockholders of CHEMPARTNER PHARMA
Annual data
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
−1.20 B
−800.00 M
−400.00 M
0.00
400.00 M
Period
Value
Change
Change %
TTM
−928.41 M
−20.46 M
−2.25%
2023
−907.94 M
−1.29 B
−339.83%
2022
378.59 M
+780.83 M
—
2021
−402.25 M
−556.80 M
−360.27%
2020
154.55 M
+15.63 M
+11.25%
2019
138.92 M
−22.15 M
−13.75%
Quarterly data
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
−900.00 M
−600.00 M
−300.00 M
0.00
300.00 M
Period
Value
Change
Change %
Q3 '24
1.24 M
+38.69 M
—
Q2 '24
−37.45 M
−11.99 M
−47.07%
Q1 '24
−25.46 M
+841.28 M
+97.06%
Q4 '23
−866.74 M
−847.31 M
−4.36 K%
Q3 '23
−19.43 M
−29.48 M
−293.32%
Q2 '23
10.05 M
+35.19 M
—
Q1 '23
−25.15 M
+619.66 M
+96.10%
Q4 '22
−644.81 M
−711.61 M
−1.07 K%